Alexandra Glucksmann

Insider Reports History

Location
Rockville, MD
Signature
/s/ Patrick J. Christmas as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alexandra Glucksmann:

Company Role Class Num Shares Value Price $ Report Date Ownership
REGENXBIO Inc. Director Common Stock 19,054 $151,860 $7.97 30 May 2025 Direct
REGENXBIO Inc. Director Stock Options (Right to Buy) 39,815 30 May 2025 Direct
REGENXBIO Inc. Director Stock Options (Right to Buy) 24,454 31 May 2024 Direct

Insider Reports Filed by Alexandra Glucksmann

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RGNX REGENXBIO Inc. 30 May 2025 2 $0 4 Director 03 Jun 2025, 16:32
RGNX REGENXBIO Inc. 31 May 2024 2 $0 4 Director 04 Jun 2024, 16:42
RGNX REGENXBIO Inc. 02 Jun 2023 2 $0 4 Director 06 Jun 2023, 17:12
RGNX REGENXBIO Inc. 03 Jun 2022 2 $0 4 Director 07 Jun 2022, 16:18
RGNX REGENXBIO Inc. 04 Jun 2021 1 $0 4 Director 08 Jun 2021, 16:19